JAKARTA, Indonesia, June 11, 2024 /PRNewswire/ -- Bayer Consumer Health Indonesia, in collaboration with the Karya Insan Sejahtera Foundation (Precious One), hosted the "First Live Stream Using Indonesian Sign Language for Self-Care Health Education" to improve knowledge and access to self-care health for people with Deaf disability in Indonesia. This first-of-its-kind sign language live stream on an e-commerce platform reached more than 100,000 people with disabilities. Bayer received a recognition from the Indonesian World Records Museum (MURI) for this initiative.
Jakarta (06/11) - Bayer Consumer Health Indonesia set a MURI record by holding " The First Live Stream Using Indonesian Sign Language for Self-Care Health Education". Osmar Susilo, Deputy Director of MURI (right), presented the MURI record certificate to Fauzan Akbar, Country Digital & eCommerce Lead for Bayer Consumer Health Indonesia (left)."
According to 2023 data, the number of people with disabilities in Indonesia reaches 22.97 million, or about 8.5% of the Indonesian population. People with disabilities are vulnerable to various risks due to the impact of limited access to information, education, and adequate healthcare. Addressing this challenge, Kinshuk Kunwar, Country Division Head of Bayer Consumer Health Indonesia & Malaysia, said, "Every individual deserves equal access to health products and information, and deserves the chance to live a fuller, healthier life. We believe when people have the power to care for themselves, they live better lives."
Bayer's commitment to self-care access and education
The "First Live Stream Using Indonesian Sign Language for Self-Care Health Education" event took place on Sunday, June 9, 2024, at 13:00 WIB on one of Indonesia's largest e-commerce platforms, marking Bayer's latest initiative to support inclusivity and empowerment. Through this campaign, people with Deaf disability received interactive self-care health education and easier access to Bayer's health products.
Welcoming the initiative, Bagja Wiranandhika Prawira, co-founder of Silang.id and Secretary of the Central Jakarta branch of Gerkatin (Movement for the Welfare of the Deaf), said, "We appreciate Bayer's active role in promoting health and empowering people with disabilities. We hope that this event will attract more public support for the disabled community's empowerment".
"First Live Stream Using Indonesian Sign Language for Self-Care Health Education" Awarded by MURI
For this initiative, Bayer received an award from MURI as the first company in Indonesia to conduct the "First Live Stream Using Indonesian Sign Language for Self-Care Health Education". Osmar Susilo, Deputy Director of MURI, said, "We support Bayer's pioneering steps in leveraging the live stream feature with sign language to educate the disabled community and help them find suitable health products. We hope this initiative will inspire more companies to support the disability community and have a widespread impact".
Fauzan Akbar, Country Digital & eCommerce Lead at Bayer Consumer Health Indonesia, added, "Thank you for the recognition from MURI and the support from all parties who have contributed to the campaign. This award further motivates us to continue to bring innovation in providing self-care health education for people with Deaf disability and the wider community in Indonesia."
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability, and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to www.bayer.com
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
